N Verses Capital, LLC Cytokinetics Inc Transaction History
N Verses Capital, LLC
- $167 Billion
- Q2 2024
A detailed history of N Verses Capital, LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, N Verses Capital, LLC holds 3,500 shares of CYTK stock, worth $195,650. This represents 0.11% of its overall portfolio holdings.
Number of Shares
3,500Holding current value
$195,650% of portfolio
0.11%Shares
1 transactions
Others Institutions Holding CYTK
# of Institutions
406Shares Held
126MCall Options Held
3.29MPut Options Held
2.01M-
Black Rock Inc. New York, NY14.7MShares$820 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.4MShares$639 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD8.14MShares$455 Million0.28% of portfolio
-
Wellington Management Group LLP Boston, MA7.51MShares$420 Million0.07% of portfolio
-
State Street Corp Boston, MA6.55MShares$366 Million0.02% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $5.26B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...